Featured image: Proton pump inhibitor use linked to an increased risk of acute kidney injury after cardiac surgery

Study: Proton Pump Inhibitors May Cause An Elevated Risk For Acute Kidney Injury After Cardiac Surgery

According to the findings of a study presented at ASN Kidney Week, patients who took proton pump inhibitors (PPIs) before undergoing cardiac surgery were more likely to develop acute kidney injury (AKI) and to die during hospitalization.  PPIs are one of the most common groups of medications prescribed by health care providers. They’re used to […]

/0 comments

Featured image: Are organic pesticides safer than conventional

Are Organic Pesticides Safer Than Conventional?

Many consumers want to go organic nowadays. After all, people are becoming more conscious of their food choices. The shift towards going organic is mainly because of the growing concern that individuals may end up with health problems because of accidentally consuming produce with traces of pesticides and chemical fertilizers. Indeed, there’s enough evidence on […]

/0 comments

Featured image: Is risperidone safe for dementia patients

Is Risperidone Safe For Dementia Patients?

Over 40 million people live with dementia worldwide, and this number is expected to triple by 2050. The condition is more common in people over the age of 65 or older. However, with the steadily increasing elderly population in many countries, dementia represents a growing and important public health issue. The first line of treatment […]

/0 comments

Featured image: SoClean Sues Philips Over Misleading Statements on CPAP Product Recall

SoClean Sues Philips For Misleading Consumers Regarding CPAP Product Recall

SoClean Inc. recently filed a lawsuit against Dutch medical device manufacturer Philips claiming that the company is deceiving the public by wrongly blaming the SoClean ozone cleaning machines for faulty design that led to the recall of millions of Philips CPAP, BiPAP, and ventilator devices.  The lawsuit was filed on October 12, 2021, in the […]

/0 comments

Featured image: Eli Lilly starts application for Alzheimer's drug

Eli Lilly Starts Application Process for Alzheimer’s Drug

Eli Lilly & Co. has begun asking the U.S. Food and Drug Administration (FDA) to approve it’s much anticipated experimental Alzheimer’s drug called donanemab.  The company is said to expect a decision from the regulatory agency by the second half of 2022. Lilly is also planning for a head-to-head study comparing its donanemab to Biogen’s […]

/0 comments

Featured image: Regular coffee intake may help lower the risk of Parkinson's

But First, Coffee: New Report Highlights the Potential Benefits of Coffee in Curbing Parkinson’s Disease

Over 10 million people worldwide are living with Parkinson’s Disease. Parkinson’s is the second most common age-related neurodegenerative disorder after Alzheimer’s.  Researchers believe that Parkinson’s disease (PD) is caused by a combination of several factors, including genetic, lifestyle, and environmental factors. An increasing number of studies, however, have focused on the environmental risk factors that […]

/0 comments

Featured image: Male birth control

Male Birth Control: Are More Contraceptive Options for Men Underway?

Women are given a plethora of choices for birth control — from pills to medical devices. Oftentimes, however, these contraceptives come with several side effects ranging from mild to rare yet severe ones.  For instance, the copper intrauterine device, paragard, has been linked to a wide array of side effects and complications. Women who have […]

/0 comments

Featured image: Zantac Class Action Lawsuits to Proceed

Branded Zantac Manufacturers Must Face Class Actions, Court Rules

The federal judge in Florida, Judge Robin Rosenberg, who’s overseeing the Zantac multidistrict litigation (MDL, has denied requests by branded drugmakers, including GlaxoSmithKline, Sanofi, Pfizer, and Boehringer Ingelheim, to dismiss class actions by consumers who suffered from severe health problems after taking the now discontinued heartburn drug, Zantac.  The global recalls of Zantac took place […]

/0 comments
1 2 3 4 5 6 25
top